Gene therapy preparations manufacturing · Illinois
Novartis Gene Therapies - Libertyville
Libertyville, IL · ~247 workers · 4 years of OSHA Injury Tracking Application data.
- A
- Excellent Safety Record
- 1.1
- Avg TCR
- 3.3
- Industry avg
- 0
- Fatalities
The verdict
Novartis Gene Therapies - Libertyville runs at 32% of its industry's injury rate - far safer than the typical Gene therapy preparations manufacturing workplace, earning a grade A.
- A
- Excellent Safety Record
- 1.1
- avg TCR · per 100 workers
- 3.3
- industry benchmark (BLS)
- 10
- recordable injuries tracked
Grade compares Novartis Gene Therapies - Libertyville's OSHA Total Case Rate of 1.1 to the Gene therapy preparations manufacturing BLS benchmark of 3.3 (32% of benchmark) across 4 years of Form 300A filings (2016–2024). <a href="/methodology">See methodology</a> for reporting-limitation caveats.
Injury rate over time
Novartis Gene Therapies - Libertyville's yearly Total Case Rate, against the 3.3 industry benchmark.
Where Novartis Gene Therapies - Libertyville falls in its industry
282 Gene therapy preparations manu establishmentsSafer than 46% of graded establishments in this industry, whose median TCR is 1.0.
Narrower to Illinois alone (the establishments it most directly competes with for workers and contracts): ranked #9 safest of 12 Gene therapy preparations manu employers in Illinois.
Trend analysis for Novartis Gene Therapies - Libertyville
Between 2020 and 2023, Novartis Gene Therapies - Libertyville's Total Case Rate improved from 1.9 to 0.0 recordable injuries per 100 full-time workers, a 100% decrease across 3 years of OSHA reporting.
The safest year on record was 2023, at a TCR of 0.0, while 2020 saw the highest rate, at 1.9, a spread of 1.9 points between the best and worst reporting years. That's a wide swing relative to the establishment's overall rate, worth checking the year-by-year table below for whether a single severe year is driving the average, rather than a sustained trend.
Summed across those 4 reporting years, Novartis Gene Therapies - Libertyville recorded 10 total injuries and illnesses, with no fatalities reported in any of those years. Readers comparing establishments should weigh the 4-year trend above alongside establishment size, since a larger workforce naturally accumulates more raw incidents even at a lower per-100-worker rate.
Verify This Employer with OSHA
The 10 injuries, 3 illnesses shown on this page for Novartis Gene Therapies - Libertyville are sourced from its own 4 years of mandatory OSHA Form 300A summaries. Cross-check the underlying establishment record directly against the federal source, name, NAICS classification, recordable case totals, and inspection history are all searchable on OSHA's Establishment-Specific Injury and Illness Data system.
Verify on OSHA Establishment SearchSource: U.S. Department of Labor, OSHA Establishment-Specific Injury and Illness Data. NAICS 325414 - Gene therapy preparations manufacturing.
DART Rate, Transparent Calculation (2023)
What is the DART rate formula?
DART (Days Away, Restricted, or Transferred) is computed by OSHA as incidents × 200,000 ÷ hours worked. The 200,000-hour denominator equals roughly 100 full-time workers, which lets establishments of very different sizes be compared directly.
0 DART incidents × 200,000 ÷ 204,675 hours worked = 0.00 DART
Methodology: 29 CFR 1904, OSHA Form 300A recordkeeping
Cross-Validating Context, Establishment vs Industry vs State
| Benchmark | TCR | Source |
|---|---|---|
| Novartis Gene Therapies - Libertyville (this establishment) | 1.07 | OSHA ITA Form 300A, 4-year avg |
| Vaccines (i.e., bacterial, virus) manufacturing industry avg | 3.30 | BLS IIF, NAICS 325414 |
| Illinois state avg (all industries) | 4.73 | OSHA ITA, state-level rollup |
Industry benchmarks: Bureau of Labor Statistics, Injuries, Illnesses, and Fatalities (IIF) program
Reportable Incident Timeline
Year-by-year reportable incidents (recordable injuries + illnesses + fatalities) submitted by Novartis Gene Therapies - Libertyville to OSHA's Injury Tracking Application. Each row anchors to OSHA's inspection records search where you can pull the underlying inspection case numbers and citations for that establishment-year.
- 2023: 0 reportable incidents · 0 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2022: 4 reportable incidents · 4 injuries, 0 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2021: 3 reportable incidents · 2 injuries, 1 illnesses, 0 fatalities - OSHA inspection records (case numbers)
- 2020: 6 reportable incidents · 4 injuries, 2 illnesses, 0 fatalities - OSHA inspection records (case numbers)
Source: OSHA Inspection Information System (IMIS) - inspection case-number records
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2023 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2022 | 1.5 | 0.7 | 4 | 0 | 0 |
| 2021 | 0.9 | 0.9 | 2 | 1 | 0 |
| 2020 | 1.9 | 1.9 | 4 | 2 | 0 |
What this grade means for you
Use this grade as a relative read on Novartis Gene Therapies - Libertyville's reported OSHA injury record, strong versus its Gene therapy preparations manufacturing peers, but not a guarantee about any single site today.
- At 32% of the Gene therapy preparations manufacturing benchmark, Novartis Gene Therapies - Libertyville reports fewer injuries than typical peers, still worth asking how safety is managed day to day. Know your rights
- Judge this record against the wider Gene therapy preparations manufacturing sector, where injury rates vary widely, before comparing it in isolation. See the industry
- Grades reflect 2016–2024 filings; check the latest establishment record straight from OSHA, or look up a different employer. Look up another
Safety grades reflect employers' self-reported OSHA Form 300A filings from 2016 to 2024 and can lag current conditions. A grade is not a guarantee that any specific workplace is safe or unsafe today. See our methodology and disclaimer.
Frequently Asked Questions
What is Novartis Gene Therapies - Libertyville's safety grade?
How many injuries has Novartis Gene Therapies - Libertyville reported?
Similar Employers
Matched by safety record across the industry, by workforce size within Illinois, and by nearby establishments in Libertyville - a different peer set than the category browse links below.
Similar TCR (~1.1)
Similar size (~247 workers)
Read our methodology - how this data is sourced, computed, and verified.
Every figure and grade on PlainSafetyScore is computed directly from OSHA's published Injury Tracking Application data and BLS industry benchmarks, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these safety grades, or report a data error. Data current as of 2016-2024 OSHA ITA release.